Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 01 2019
accepted: 20 05 2019
revised: 09 07 2019
pubmed: 27 6 2019
medline: 4 12 2019
entrez: 27 6 2019
Statut: epublish

Résumé

Enteropathogenic E. coli (EPEC) is an extracellular diarrheagenic human pathogen which infects the apical plasma membrane of the small intestinal enterocytes. EPEC utilizes a type III secretion system to translocate bacterial effector proteins into its epithelial hosts. This activity, which subverts numerous signaling and membrane trafficking pathways in the infected cells, is thought to contribute to pathogen virulence. The molecular and cellular mechanisms underlying these events are not well understood. We investigated the mode by which EPEC effectors hijack endosomes to modulate endocytosis, recycling and transcytosis in epithelial host cells. To this end, we developed a flow cytometry-based assay and imaging techniques to track endosomal dynamics and membrane cargo trafficking in the infected cells. We show that type-III secreted components prompt the recruitment of clathrin (clathrin and AP2), early (Rab5a and EEA1) and recycling (Rab4a, Rab11a, Rab11b, FIP2, Myo5b) endocytic machineries to peripheral plasma membrane infection sites. Protein cargoes, e.g. transferrin receptors, β1 integrins and aquaporins, which exploit the endocytic pathways mediated by these machineries, were also found to be recruited to these sites. Moreover, the endosomes and cargo recruitment to infection sites correlated with an increase in cargo endocytic turnover (i.e. endocytosis and recycling) and transcytosis to the infected plasma membrane. The hijacking of endosomes and associated endocytic activities depended on the translocated EspF and Map effectors in non-polarized epithelial cells, and mostly on EspF in polarized epithelial cells. These data suggest a model whereby EPEC effectors hijack endosomal recycling mechanisms to mislocalize and concentrate host plasma membrane proteins in endosomes and in the apically infected plasma membrane. We hypothesize that these activities contribute to bacterial colonization and virulence.

Identifiants

pubmed: 31242273
doi: 10.1371/journal.ppat.1007851
pii: PPATHOGENS-D-18-02495
pmc: PMC6615643
doi:

Substances chimiques

Membrane Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007851

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Traffic. 2007 Feb;8(2):110-23
pubmed: 17156409
Int J Mol Sci. 2016 Aug 29;17(9):
pubmed: 27589719
Nature. 1999 Sep 16;401(6750):286-90
pubmed: 10499588
J Cell Biol. 2011 Oct 31;195(3):525-36
pubmed: 22042622
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Mol Biol Cell. 2005 Apr;16(4):2028-38
pubmed: 15689494
Metallomics. 2009;1(3):249-55
pubmed: 20161024
Methods Cell Biol. 2015;130:271-88
pubmed: 26360040
Curr Opin Cell Biol. 2002 Aug;14(4):428-33
pubmed: 12383793
Mol Biol Cell. 2009 Jan;20(1):544-55
pubmed: 18987340
J Biol Chem. 2000 May 19;275(20):15207-19
pubmed: 10809756
Dev Cell. 2004 Nov;7(5):771-6
pubmed: 15525538
Curr Biol. 2014 Jun 2;24(11):1187-98
pubmed: 24835460
J Mol Biol. 2016 Aug 28;428(17):3399-407
pubmed: 27261256
Am J Physiol Cell Physiol. 2013 Jan 1;304(1):C38-48
pubmed: 23015545
Traffic. 2014 Mar;15(3):292-308
pubmed: 24372966
Am J Physiol Renal Physiol. 2003 May;284(5):F893-901
pubmed: 12676734
J Cell Biol. 2007 Sep 24;178(7):1265-78
pubmed: 17893247
Mol Biol Cell. 2001 Jun;12(6):1843-57
pubmed: 11408590
Curr Opin Microbiol. 2006 Feb;9(1):40-5
pubmed: 16406772
J Cell Sci. 2001 Sep;114(Pt 18):3309-21
pubmed: 11591819
Cell Microbiol. 2009 Feb;11(2):309-22
pubmed: 19046338
Infect Immun. 2018 Sep 21;86(10):
pubmed: 30037792
Curr Opin Cell Biol. 2019 Feb;56:22-33
pubmed: 30227382
J Comp Neurol. 2008 Feb 1;506(4):708-32
pubmed: 18067149
Cell Mol Immunol. 2017 Mar;14(3):237-244
pubmed: 27796284
PLoS Pathog. 2010 Aug 12;6(8):e1000949
pubmed: 20711357
Cell Logist. 2011 Mar;1(2):57-68
pubmed: 21686255
Infect Immun. 2003 Dec;71(12):7069-78
pubmed: 14638797
Cell. 2012 Feb 17;148(4):803-15
pubmed: 22341450
Mol Microbiol. 2011 Jun;80(6):1420-38
pubmed: 21488979
J Infect Dis. 2011 Sep 1;204(5):695-703
pubmed: 21810914
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):680-5
pubmed: 10639139
Traffic. 2000 Feb;1(2):124-40
pubmed: 11208093
Mol Microbiol. 2006 Apr;60(2):349-63
pubmed: 16573685
Am J Physiol Renal Physiol. 2002 Jun;282(6):F998-1011
pubmed: 11997316
Histochem Cell Biol. 2007 May;127(5):463-72
pubmed: 17308935
J Cell Biol. 2011 Oct 3;195(1):71-86
pubmed: 21969467
J Cell Sci. 2015 Nov 15;128(22):4183-95
pubmed: 26446261
Cell Host Microbe. 2007 Nov 15;2(5):340-51
pubmed: 18005755
Methods Enzymol. 2011;498:349-61
pubmed: 21601685
Mol Biol Cell. 2011 Jul 15;22(14):2436-47
pubmed: 21613538
Cell Microbiol. 2007 Feb;9(2):438-49
pubmed: 16965516
Eur J Cell Biol. 2009 Jun;88(6):325-41
pubmed: 19327867
J Cell Sci. 2012 Sep 1;125(Pt 17):4049-57
pubmed: 22685325
Cell Host Microbe. 2008 Feb 14;3(2):104-13
pubmed: 18312845
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
PLoS Pathog. 2011 May;7(5):e1002050
pubmed: 21589900
J Cell Sci. 2004 May 1;117(Pt 11):2183-92
pubmed: 15126620
J Cell Biol. 2000 May 15;149(4):901-14
pubmed: 10811830
Clin Microbiol Rev. 1998 Jan;11(1):142-201
pubmed: 9457432
Nat Rev Mol Cell Biol. 2008 Jul;9(7):574-82
pubmed: 18523436
Curr Opin Microbiol. 2009 Feb;12(1):101-9
pubmed: 19144561
Nat Struct Mol Biol. 2009 Aug;16(8):853-60
pubmed: 19620963
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Cell Microbiol. 2014 Nov;16(11):1693-705
pubmed: 24898821
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2789-94
pubmed: 21282656
Jpn J Med Sci Biol. 1998;51 Suppl:S91-100
pubmed: 10211441
Biochim Biophys Acta. 2012 Mar;1820(3):264-81
pubmed: 21968002
Trends Cell Biol. 2000 Mar;10(3):85-8
pubmed: 10675900
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17955-60
pubmed: 17093049
Infect Immun. 2010 Aug;78(8):3316-22
pubmed: 20515931
J Cell Sci. 2006 May 15;119(Pt 10):2095-106
pubmed: 16638813
Mol Microbiol. 2003 Jan;47(1):209-21
pubmed: 12492865
J Cell Sci. 2008 Nov 15;121(Pt 22):3824-33
pubmed: 18957512
Am J Physiol Cell Physiol. 2006 Jan;290(1):C298-304
pubmed: 16135541
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Cell Microbiol. 2017 Nov;19(11):
pubmed: 28618099
J Bacteriol. 2006 Apr;188(8):3110-5
pubmed: 16585770
Front Cell Infect Microbiol. 2016 Aug 24;6:87
pubmed: 27606286
Cell Microbiol. 2007 Jul;9(7):1782-95
pubmed: 17451412
Nature. 1998 Jul 30;394(6692):494-8
pubmed: 9697774
Cell. 2006 Jan 13;124(1):133-45
pubmed: 16413487
J Bacteriol. 2009 Jan;191(1):347-54
pubmed: 18952797
J Microsc. 2008 Sep;231(3):524-8
pubmed: 18755008
Traffic. 2010 Oct;11(10):1370-9
pubmed: 20604897
Trends Microbiol. 2018 Apr;26(4):266-283
pubmed: 29477730
PLoS One. 2017 Jun 21;12(6):e0179122
pubmed: 28636623
Dev Cell. 2004 Aug;7(2):217-28
pubmed: 15296718
Cell. 2005 Dec 2;123(5):875-88
pubmed: 16325581
Cell Microbiol. 2007 Jan;9(1):131-41
pubmed: 16889624
Gut Microbes. 2012 May-Jun;3(3):267-71
pubmed: 22572833

Auteurs

Ephrem G Kassa (EG)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Efrat Zlotkin-Rivkin (E)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Gil Friedman (G)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Rachana P Ramachandran (RP)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Naomi Melamed-Book (N)

Bio-imaging Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Aryeh M Weiss (AM)

Bio-imaging Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel.

Michael Belenky (M)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Dana Reichmann (D)

Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Proteomics and Mass Spectrometry Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

William Breuer (W)

Proteomics and Mass Spectrometry Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ritesh Ranjan Pal (RR)

Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ilan Rosenshine (I)

Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.

Lynne A Lapierre (LA)

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.

James R Goldenring (JR)

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.

Benjamin Aroeti (B)

Department of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH